dc.contributor.author
Auer, Timo Alexander
dc.contributor.author
Fehrenbach, Uli
dc.contributor.author
Grieser, Christian
dc.contributor.author
Penzkofer, Tobias
dc.contributor.author
Geisel, Dominik
dc.contributor.author
Schmelzle, Moritz
dc.contributor.author
Müller, Tobias
dc.contributor.author
Bläker, Hendrik
dc.contributor.author
Seehofer, Daniel
dc.contributor.author
Denecke, Timm
dc.date.accessioned
2022-10-26T11:58:10Z
dc.date.available
2022-10-26T11:58:10Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/36646
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36359
dc.description.abstract
Purpose: To differentiate subtypes of hepatocellular adenoma (HCA) based on enhancement characteristics in gadoxetic acid (Gd-EOB) magnetic resonance imaging (MRI).
Materials and methods: Forty-eight patients with 79 histopathologically proven HCAs who underwent Gd-EOB-enhanced MRI were enrolled (standard of reference: surgical resection). Two blinded radiologists performed quantitative measurements (lesion-to-liver enhancement) and evaluated qualitative imaging features. Inter-reader variability was tested. Advanced texture analysis was used to evaluate lesion heterogeneity three-dimensionally.
Results: Overall, there were 19 (24%) hepatocyte nuclear factor (HNF)-1a-mutated (HHCAs), 37 (47%) inflammatory (IHCAs), 5 (6.5%) b-catenin-activated (bHCA), and 18 (22.5%) unclassified (UHCAs) adenomas. In the hepatobiliary phase (HBP), 49.5% (39/79) of all adenomas were rated as hypointense and 50.5% (40/79) as significantly enhancing (defined as > 25% intralesional GD-EOB uptake). 82.5% (33/40) of significantly enhancing adenomas were IHCAs, while only 4% (1/40) were in the HHCA subgroup (p < 0.001). When Gd-EOB uptake behavior was considered in conjunction with established MRI features (binary regression model), the area under the curve (AUC) increased from 0.785 to 0.953 for differentiation of IHCA (atoll sign + hyperintensity), from 0.859 to 0.903 for bHCA (scar + hyperintensity), and from 0.899 to 0.957 for HHCA (steatosis + hypointensity). Three-dimensional region of interest (3D ROI) analysis showed significantly increased voxel heterogeneity for IHCAs (p = 0.038).
Conclusion: Gd-EOB MRI is of added value for subtype differentiation of HCAs and reliably identifies the typical heterogeneous HBP uptake of IHCAs. Diagnostic accuracy can be improved significantly by the combined analysis of established morphologic MR appearances and intralesional Gd-EOB uptake.
Key points: •Gd-EOB-enhanced MRI is of added value for subtype differentiation of HCA. •IHCA and HHCA can be identified reliably based on their typical Gd-EOB uptake patterns, and accuracy increases significantly when additionally taking established MR appearances into account. •The small numbers of bHCAs and UHCAs remain the source of diagnostic uncertainty.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Magnetic resonance imaging
en
dc.subject
Hepatic neoplasms
en
dc.subject
Hepatocellular adenoma
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00330-020-06726-8
dcterms.bibliographicCitation.journaltitle
European Radiology
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
3497
dcterms.bibliographicCitation.pageend
3506
dcterms.bibliographicCitation.volume
30
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
32086574
dcterms.isPartOf.issn
0938-7994
dcterms.isPartOf.eissn
1432-1084